More

    Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress



    [
    Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
    [og_img]
    https://www.investing.com/news/press-releases/reviva-to-present-brilaroxazine-topline-data-for-longterm-ole-portion-of-recover-study-in-schizophrenia-at-2025-sirs-congress-93CH-3956216


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img